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iverse stimuli initiate the activation of apoptotic
signaling pathways that often causes nuclear DNA
fragmentation. Here, we report a new antiapoptotic
protein, a caspase-activated DNase (CAD) inhibitor that
interacts with ASK1 (CIIA). CIIA, by binding to apoptosis
signal-regulating kinase 1 (ASK1), inhibits oligomerization-
induced ASK1 activation. CIIA also associates with CAD
and inhibits the nuclease activity of CAD without affecting
D
 
caspase-3–mediated ICAD cleavage. Overexpressed CIIA
 
reduces H
 
2
 
O
 
2
 
- and tumor necrosis factor-
 
 
 
–induced apopto-
sis. CIIA antisense oligonucleotides, which abolish expression
of endogenous CIIA in murine L929 cells, block the inhibitory
effect of CIIA on ASK1 activation, deoxyribonucleic acid
fragmentation, and apoptosis. These ﬁndings suggest that
CIIA is an endogenous antagonist of both ASK1- and CAD-
mediated signaling.
 
Introduction
 
Apoptosis, or programmed cell death, is a fundamental
cellular process for the self-elimination of unwanted or
damaged cells. Apoptosis occurs during a variety of biological
processes in multicellular organisms including development
and pathogenesis of many diseases. Apoptotic cells undergo
morphological changes such as chromosomal condensation,
loss of mitochondrial membrane potential, and formation of
apoptotic bodies. These morphological events follow bio-
chemical events that include activation of caspases, changes
in plasma membrane composition, and DNA fragmentation
(Nagata, 1997; Green and Reed, 1998).
Caspases-3 and -7 have been shown to stimulate the frag-
mentation of chromosomal DNA through the activation of
caspase-activated DNase (CAD), also known as caspase-acti-
vated nuclease and DNA fragmentation factor (DFF) 40
(Liu et al., 1997, 1998; Enari et al., 1998; Sakahira et al.,
1998). In healthy cells, CAD–caspase-activated nucleus–
DFF40 exists as a complex with its inhibitor, ICAD–DFF45.
When the apoptotic pathway is activated, caspases cleave
ICAD–DFF45, which results in the release of CAD–DFF40
from the complex and stimulation of its nuclease activity
(Liu et al., 1997; Sakahira et al., 1998).
The MAPK signaling pathways mediate a variety of cellu-
lar events, including cell proliferation, differentiation, and
death (Minden and Karin, 1997; Ip and Davis, 1998;
Schaeffer and Weber, 1999). The mammalian MAPK sub-
families include extracellular signal-regulated kinase, c-Jun
NH
 
2
 
-terminal kinase/stress-activated protein kinase (JNK/
SAPK), and p38 (Minden and Karin, 1997; Ip and Davis,
1998; Schaeffer and Weber, 1999). SAPK/JNK and p38 are
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stimulated in response to a variety of cellular stresses, includ-
ing UV light, osmotic and heat shock, DNA damaging
agents, and proinflammatory cytokines (Derijard et al.,
1994; Galcheva-Gargova et al., 1994; Han et al., 1994; Kyr-
iakis et al., 1994). The JNK–SAPK and p38 pathways have
been shown to be associated with mechanisms of apoptotic
cell death under certain conditions (Xia et al., 1995; Verheij
et al., 1996; Minden and Karin, 1997; Ip and Davis, 1998).
Apoptosis signal-regulating kinase 1 (ASK1) is a MAPK
kinase kinase that activates the JNK/SAPK and the p38 sig-
naling cascades (Ichijo et al., 1997). ASK1 is shown to be
involved in apoptosis, induced by tumor necrosis factor
(TNF)-
 
 
 
, Fas, and cellular stresses (Ichijo et al., 1997).
Here, we report the identification of an antiapoptotic pro-
tein that physically interacts with both ASK1 and CAD.
This protein is named a CAD inhibitor that interacts with
ASK1 (CIIA). CIIA inhibits stress- or TNF-
 
 
 
–induced
ASK1 activation. Furthermore, CIIA inhibits CAD-medi-
ated DNA fragmentation. Thus, our data suggest that CIIA
functions as an endogenous antagonist of ASK1 and CAD
activities.
 
Results
 
Isolation of a cDNA clone of CIIA
 
To better understand the mechanism underlying the regula-
tion of ASK1 function, we searched initially for ASK1-bind-
ing proteins using the yeast two-hybrid screening method
 
with a mouse adult brain cDNA library. From the two-
hybrid study, we identified a new gene that encoded a 221-aa
protein (Fig. 1 A). Surprisingly, the same gene was also iden-
tified in an independent yeast two-hybrid screening experi-
ment using CAD as the bait. On the basis of the two-hybrid
results, we named the protein encoded by this gene CIIA.
We also found a human EST clone (GenBank/EMBL/
DDBJ accession no. AA432040) by BLAST searches that
has a high level of homology with the mouse CIIA gene.
CIIA has no known conserved protein motif. A mouse mul-
tiple-tissue Northern blot analysis using a mouse CIIA
cDNA probe revealed that a transcript of 1 kb was highly ex-
pressed in many adult tissues including heart, brain, liver,
and kidney (Fig. 1 B). Immunoblot analysis using rabbit
polyclonal anti-CIIA antibody identified a 26-kD protein in
mouse brain tissue (Fig. 1 C) and in various mammalian cell
lines, including murine fibrosarcoma L929, human neuro-
glioma H4, and human cervical cancer HeLa cells (not de-
picted). Immunostaining using anti-CIIA antibody showed
that CIIA protein was present in both the nucleus and cyto-
plasm in cultured cells (unpublished data).
 
CIIA physically interacts with ASK1 and CAD
 
In our initial studies, NIH 3T3 cells stably expressing HA-
tagged CIIA (HA-CIIA) were subjected to glycerol gradient
fractionation. After cell lysates were subjected to centrifuga-
tion at 1,000 
 
g
 
, the resulting soluble fraction was subjected
to glycerol gradient centrifugation. Immunoblot analysis of
Figure 1.  Primary structure of CIIA. 
(A) Predicted amino acid sequences of the 
mouse CIIA. The cDNA sequence data of 
the mouse CIIA are available from GenBank/
EMBL/DDBJ under accession no. AF373710. 
(B) Distribution of the CIIA transcript in 
mouse tissues. A multiple-tissue Northern 
blot membrane was probed with 
32P-labeled 
BamHI–AccI fragment (714 bp) of mouse 
CIIA cDNA. (C) Immunodetection of CIIA 
protein in adult mouse brain tissue. 50  g 
cell lysates were analyzed by immunoblot 
(IB) using a rabbit preimmune IgG or anti-
CIIA antibody. The anti-CIIA antibody was 
produced from rabbits immunized with 
hexahistidine (His)-tagged CIIA and affinity-
purified. Immunoblots with anti-HA antibody 
of the lysates from 293T cells transfected 
with pcDNA3-HA empty vector or 
pcDNA3-HA-CIIA were also shown.T
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the glycerol gradient fractions revealed that the majority of
ASK1 and CIIA were present in the same fractions (Fig. 2,
fractions 10–16). CIIA and CAD also resided in the same
fractions (Fig. 2, fractions 10–17). These fractionation re-
sults suggest that CIIA is in close proximity to ASK1 and to
CAD. Next, we transiently transfected NIH 3T3 cells with
CIIA plus CAD or CIIA plus ASK1 constructs and exam-
ined subcellular distribution of the proteins by immunofluo-
rescence microscopy. Double-labeled immunostaining data
revealed that ectopic CIIA was located in both the nucleus
and the cytoplasm and that its distribution was overlapped
with that of CAD or ASK1 (Fig. S1, available at http://
www.jcb.org/cgi/content/full/jcb.200303003/DC1).
To test whether CIIA interacted directly with ASK1, we
performed an in vitro binding study using recombinant
GST-fused CIIA variants and in vitro–translated 
 
35
 
S-labeled
ASK1 (Fig. 3 A). Both full-length CIIA and CIIA-
 
 
 
N asso-
ciated with ASK1, whereas CIIA-
 
 
 
C and CIIA-CEN failed
to bind to ASK1 (Fig. 3 A). In separate in vitro binding ex-
periments, GST-CIIA interacted with in vitro–translated
 
35
 
S-labeled full-length ASK1, ASK1-
 
 
 
C, and ASK1-NT,
but not with ASK1-
 
 
 
N (Fig. 3 B). Thus, these data suggest
that CIIA binds the NH
 
2
 
-terminal half region of ASK1.
Other ASK1-interacting proteins such as TRAF2, GSTM1,
and Daxx have been also shown to bind the NH
 
2
 
-terminal
region of ASK1 (Chang et al., 1998; Liu et al., 2000; Cho et
al., 2001). Therefore, we examined whether CIIA could af-
fect the binding of ASK1 with TRAF2, GSTM1, or Daxx. A
coimmunoprecipitation study revealed that CIIA inhibits
the physical interaction of ASK1 with TRAF2, GSTM1, or
Daxx (Fig. S2, available at http://www.jcb.org/cgi/content/
full/jcb.200303003/DC1).
Next, we tested a physical interaction between two endog-
enous CIIA and ASK1 proteins in intact cells by coimmu-
noprecipitation. Lysates of mouse embryonic fibroblasts
(MEFs) or mouse brain tissue were subjected to immuno-
Figure 2.  Glycerol gradient analysis of CIIA, ASK1, and CAD 
proteins in NIH 3T3 cells. Lysates from NIH 3T3 cells stably expressing 
HA-CIIA were subjected to centrifugation at 1,000 g for 10 min. The 
resulting soluble fraction was subjected to 15–35% (wt/wt) linear 
glycerol gradient centrifugation. Equal volumes of the 22 collected 
fractions were analyzed by SDS-PAGE and immunoblotting with 
anti-HA, anti-ASK1, anti-CAD, and anti-ICAD antibodies.
Figure 3.  CIIA physically interacts 
with ASK1. (A) 
35S-Labeled ASK1 was 
produced by in vitro translation and 
incubated at 4 C for 3 h with GST-fused 
CIIA variants immobilized on glutathione-
agarose beads. The bead-bound proteins 
were eluted and analyzed by SDS-PAGE 
and autoradiography. A lower part of the 
polyacrylamide gel was cut and stained 
with Coomassie brilliant blue to show 
the amount of GST-fused CIIA variants 
bound on the beads. (B) Binding of in 
vitro–translated 
35S-labeled ASK1 vari-
ants to GST-CIIA was examined as in A. 
In A and B, the input 
35S-labeled proteins 
(10%) were also shown. (C) The soluble 
fraction of mouse brain tissue or MEF 
homogenates was precleared with rabbit 
preimmune IgG and subjected to immuno-
precipitation (IP) with rabbit anti-CIIA 
antibody, or rabbit preimmune IgG. The 
resulting precipitates were subjected to 
SDS-PAGE and analyzed by immuno-
blotting (IB) with anti-ASK1 antibody. 
Immunoblotting of cell lysates (5% of 
total) with anti-ASK1 antibody was also 
shown. (D) 293T cells were transfected 
with expression vectors encoding ASK1-Flag and HA-CIIA as indicated. After 48 h of transfection, 
the cells were untreated or treated with 500  M H2O2 for 1 h. Cell lysates were subjected 
to immunoprecipitation with anti-HA antibody, and the resulting immunoprecipitates were 
subjected to immunoblot analysis with anti-Flag antibody. Cell lysates were also subjected to 
immunoblot analysis with the indicated antibodies. (E) L929 cells were untreated or treated with 
500  M H2O2 for indicated time periods. Cell lysates were subjected to immunoprecipitation 
and the resulting immunoprecipitates were analyzed by immunoblotting as in C. Cell lysates 
(5% of total) were also subjected to immunoblot analysis with anti-ASK1 or anti-CIIA antibody.T
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precipitation using anti-CIIA antibody, and the resulting
immunoprecipitates were analyzed by immunoblotting with
anti-ASK1 antibody. Immunoblot data revealed that CIIA
physically associates with ASK1 in MEFs and cells from
mouse brain (Fig. 3 C). Physical association between CIIA
and ASK1 was also confirmed by coimmunoprecipitation in
293T cells transfected with plasmids encoding HA-tagged
CIIA and Flag-tagged ASK1 (ASK1-Flag; Fig. 3 D). Inter-
estingly, the interaction between ectopic CIIA and ASK1
was increased by H
 
2
 
O
 
2
 
 treatment. Subsequently, we exam-
ined a time course of the H
 
2
 
O
 
2
 
 action on the physical associ-
ation of endogenous CIIA and ASK1 proteins in L929 cells
(Fig. 3 E). Coimmunoprecipitation results indicated that
H
 
2
 
O
 
2
 
-induced enhancement of the interaction between the
two endogenous proteins was maximal at 1 h.
Next, we examined in vitro binding between CIIA and
CAD using recombinant GST-CIIA variants and in vitro–
translated 
 
35
 
S-Labeled CAD. 
 
35
 
S-labeled CAD bound to
CIIA and CIIA-
 
 
 
C, but not to CIIA-
 
 
 
N or CIIA-CEN
(Fig. 4 A). In comparison, 
 
35
 
S-labeled ICAD-L did not in-
teract with CIIA in vitro. We also conducted in vitro bind-
ing studies using 
 
35
 
S-labeled CIIA and GST-fused CAD
variants. 
 
35
 
S-Labeled CIIA bound to CAD, CAD-NT, and
CAD-
 
 
 
C, but not to CAD-
 
 
 
N (Fig. 4 B). Interestingly,
CAD-
 
 
 
N lacks amino acid residues 1–83, which is homolo-
gous to a NH
 
2
 
-terminal domain of CIDE proteins (the
CIDE-N domain; Inohara et al., 1998). It was reported pre-
viously that the NH
 
2
 
-terminal domain of CAD is involved
in binding to ICAD (Inohara et al., 1999). Therefore, we
examined whether in vitro–translated 
 
35
 
S-labeled CIIA can
form a tertiary complex with the CAD–ICAD complex. 
 
35
 
S-
Labeled CIIA bound to the recombinant CAD–ICAD com-
plex, but not to ICAD (Fig. 4 C).
Next, we examined the physical interaction between CIIA
and CAD in 293T cells expressing HA-CIIA and CAD-Flag
(Fig. 4 D). Immunoblot analysis of the HA immunoprecipi-
tates revealed a physical association of CIIA with CAD in
the cotransfected cells. We also examined whether ICAD
Figure 4.  CIIA physically interacts 
with CAD. (A) 
35S-Labeled CAD was 
produced by in vitro translation and 
applied to GST-fused CIIA variants 
immobilized on glutathione-agarose 
beads. The bead-bound proteins were 
eluted, separated by SDS-PAGE, and 
autoradiography. The polyacrylamide 
gel was also stained with Coomassie 
brilliant blue. (B) 
35S-labeled CIIA was 
produced by in vitro translation and 
examined for in vitro binding to GST-
fused CAD variants as in A. In A and B, 
the input 
35S-labeled proteins (10%) 
were also shown. (C) Recombinant 
T7-ICAD–CAD complex or T7-ICAD 
alone was incubated at 4 C for 3 h with 
in vitro–translated 
35S-labeled CIIA, 
and immunoprecipitated with mouse 
preimmune IgG or mouse monoclonal 
anti-T7 antibody. The resulting precipi-
tates were analyzed by SDS-PAGE and 
autoradiography. The input (10%) of 
35S-labeled CIIA, CAD, and T7-ICAD 
was also shown. (D) 293T cells were 
transfected for 48 h with indicated com-
binations of plasmids encoding CAD-
Flag, HA-ICAD-L, ICAD-L, and HA-CIIA. 
Cell lysates were subjected to immuno-
precipitation with anti-HA antibody, and 
the resulting HA immunoprecipitates 
were subjected to immunoblot analysis 
with anti-Flag antibody. Cell lysates 
(10% of total) were also subjected to 
immunoblot analysis with indicated 
antibodies. (E) Physical interaction 
between endogenous CIIA and CAD. 
The lysates of mouse brain tissue and 
MEFs were subjected to immunoprecipi-
tation with rabbit preimmune IgG or 
anti-CIIA antibody, and the resulting 
precipitates were subjected to immuno-
blot analysis with rabbit anti-CAD anti-
body. Immunoblotting of the cell lysates (5% of total) was also shown. (F) L929 cells were untreated or treated with 500  M H2O2 for indicated 
time periods. Cell lysates were subjected to immunoprecipitation, and the immunoprecipitates were subjected to immunoblot analysis as in 
E. Cell lysates (5% of total) were also subjected to immunoblot analysis with anti-CAD or anti-CIIA antibody.T
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could inhibit the interaction between CAD and CIIA. Coex-
pression of ICAD-L did not interfere with the interaction
between HA-CIIA and CAD-Flag (Fig. 4 D). In fact, coex-
pression of ICAD-L resulted in an increase in the amount of
CAD-Flag coimmunoprecipitated with HA-CIIA, presum-
ably because of an increase in the expression of functional
CAD-Flag. ICAD-L has been shown not only to inhibit
CAD activity but also to enhance the expression of func-
tional CAD (Enari et al., 1998; Sakahira et al., 1999). Phys-
ical association of two endogenous CIIA and CAD proteins
was also confirmed in MEFs and cells from mouse brain by
coimmunoprecipitation (Fig. 4 E). Next, we examined a
possible effect of H
 
2
 
O
 
2
 
 on the physical interaction between
endogenous CIIA and CAD in L929 cells. L929 cells were
unexposed or exposed to H
 
2
 
O
 
2
 
 for various times, and cell ly-
sates were analyzed by coimmunoprecipitation. Physical in-
teraction between CIIA and CAD was maximal after 30 min
of an exposure of L929 cells to H
 
2
 
O
 
2
 
 (Fig. 4 F).
 
CIIA inhibits the kinase activity of ASK1
 
Next, we investigated whether CIIA could affect the kinase
activity of ASK1. Ectopic ASK1 was stimulated by an ex-
posure of the transfected cells to UV light or H
 
2
 
O
 
2
 
 or by
coexpression of TRAF2 (Fig. 5 A). Expression of CIIA
suppressed UV-, H
 
2
 
O
 
2
 
-, and TRAF2-stimulated ASK1 ac-
tivities in the cells. In comparison, CIIA neither bound
to nor inhibited MAPK/extracellular signal–regulated ki-
nase kinase kinase 1 (MEKK1), another MAPK kinase
kinase that stimulates the JNK–SAPK pathway (Figs. S3
and S4, available at http://www.jcb.org/cgi/content/full/jcb.
200303003/DC1).
Homo-oligomerization of ASK1 is one mechanism for
ASK1 activation (Gotoh and Cooper, 1998; Liu et al.,
2000). Therefore, we examined whether CIIA interferes
with ASK1 oligomerization (Fig. 5 B). 293T cells were
transfected with ASK1-Flag and ASK1-HA constructs in the
absence or presence of the CIIA construct. Coimmunopre-
cipitation analysis indicated that ASK1-HA was found to be
associated with ASK1-Flag in the transfected cells. The
ASK1 homo-oligomerization was inhibited by coexpression
of CIIA. These results suggest that CIIA may inhibit ASK1
activation, at least in part, by the suppression of ASK1
homo-oligomerization.
Next, we examined the effect of CIIA on the signaling
events downstream of ASK1. ASK1 activation can induce
stimulation of JNK, which in turn enhances the transcrip-
tion-stimulating activity of c-Jun (Ichijo et al., 1997; Ip and
Davis, 1998). Overexpressed ASK1-induced JNK1 activation
and this ASK1-dependent JNK1 activation was blocked by
CIIA expression in transfected 293T cells (Fig. 5 C). CIIA
Figure 5.  CIIA inhibits ASK1 activation. 
(A) CIIA inhibits ASK1 activation in 
transfected cells. 293T cells were trans-
fected for 48 h with the combinations 
of ASK1-Flag, HA-CIIA, and TRAF2 
constructs as indicated. Where noted, 
cells were treated with 60 J/m
2 UV light 
or 500  M H2O2 and incubated further 
for 20 min. Cell lysates were subjected 
to immunoprecipitation with anti-Flag 
antibody, and the resulting precipitates 
were examined for ASK1 activity by the 
immunocomplex kinase assay with GST-
MKK6(K82A) as the substrate. Cell 
lysates were also examined by immuno-
blot analysis with the indicated antibodies. 
(B) CIIA inhibits ASK1 homo-oligomer-
ization. 293T cells were transfected for 
48 h with expression vectors encoding 
ASK1-Flag, HA-ASK1, and CIIA, as 
indicated. Cell lysates were subjected 
to immunoprecipitation with anti-Flag 
antibody, and the resulting Flag immuno-
precipitates were subjected to immuno-
blot analysis with anti-HA antibody. Cell lysates were also immunoblotted with the indicated 
antibodies. (C) CIIA inhibits ASK1-dependent JNK activation. 293T cells were transfected 
for 48 h with expression vectors for JNK1-Flag, ASK1, or HA-CIIA as indicated. Cell lysates 
were subjected to immunoprecipitation with anti-Flag antibody, and the resulting Flag 
immunoprecipitates were examined for JNK1 activity by the immunocomplex kinase assay. 
(D) CIIA inhibits the ASK1-induced stimulation of the transcriptional activity of c-Jun. 293T 
cells were transfected with pFR-Luc and pcDNA3- -gal and the indicated combinations of 
plasmids for c-Jun, ASK1, and CIIA. After 48 h of transfection, the cells were lysed and the 
soluble fraction of cell lysates was assayed for both luciferase and  -galactosidase activities. 
Luciferase activity was normalized to  -galactosidase activity. Data are the mean of triplicate 
determinations   SEM.T
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also inhibited the ASK1-induced stimulation of the transcrip-
tion-stimulating activity of c-Jun (Fig. 5 D). CIIA did not in-
teract physically with JNK1 or c-Jun (Fig. S3, available at
http://www.jcb.org/cgi/content/full/jcb.200303003/DC1).
 
CIIA inhibits the DNase activity of CAD
 
Next, we investigated whether CIIA could modulate the
DNase activity of CAD. An in vitro CAD assay showed that
treatment of a recombinant CAD–ICAD-L complex with cas-
pase-3 resulted in the stimulation of the nuclease activity of
CAD (Fig. 6 A). CIIA, in the form of a GST fusion protein,
inhibited the caspase-3–induced stimulation of CAD activity,
whereas GST alone or GST-ICAD-L did not. Caspase-3–
dependent CAD activation was also inhibited by CIIA-
 
 
 
C,
but not by CIIA-
 
 
 
N or CIIA-CEN (Fig. 6 B). To further un-
derstand the mechanism underlying the inhibitory action of
CIIA on CAD activation, we examined whether CIIA could
block a caspase-3–catalyzed cleavage of ICAD. In vitro cleavage
results indicated that CIIA did not inhibit a cleavage of ICAD
by caspase-3 (Fig. 6 C). Next, recombinant CAD–ICAD com-
plex was pretreated with caspase-3 and examined for the nu-
clease activity in the absence or presence of CIIA. CIIA inhib-
ited DNA fragmentation mediated by caspase-3–pretreated
CAD–ICAD complex (Fig. 6 D). Collectively, these results
suggest that CIIA blocks the CAD-dependent DNA fragmen-
tation through an inhibition of the DNase activity of CAD.
Next, the effect of CIIA on CAD-mediated DNA frag-
mentation was examined in 293T cells. The cells were trans-
 
fected with various combinations of plasmids encoding
CAD-Flag, ICAD-L, a constitutively active caspase-3, and
HA-CIIA (Fig. 6 E). Expression of CAD and ICAD-L with
the caspase-3 enhanced DNA fragmentation in the trans-
fected cells. Coexpression of CIIA inhibited the caspase-3/
CAD-dependent DNA fragmentation. Together, our data
suggest that CIIA suppresses the DNase activity of CAD.
 
CIIA reduces TNF-
 
 
 
– and H2O2-induced apoptosis
To further assess the function of CIIA, HA-CIIA construct
was stably transfected into 293T cells, in which a level of en-
dogenous CIIA was quite low (unpublished data). Expres-
sion of HA-CIIA did not affect endogenous levels of ASK1,
CAD, or ICAD in 293 cells (unpublished data). TNF- 
treatment of 293-neo control cells resulted in ASK1 activa-
tion, however, TNF- –induced ASK1 activation was im-
paired in the cells expressing HA-CIIA (293-CIIA cells; Fig.
7 A). CIIA overexpression also inhibited TNF- –induced
activation of JNK1, a downstream kinase of ASK1. Further-
more, TNF- –induced DNA fragmentation was lowered in
293-CIIA cells, compared with that of 293-neo cells (Fig. 7
B). ASK1 plays a crucial role in the mechanisms of TNF- –
and stress-induced apoptosis through the activation of stress-
activated MAPKs, including JNK/SAPK (Ichijo et al.,
1997), and the mitochondria-dependent activation of cas-
pases (Hatai et al., 2000). Therefore, we examined the ef-
fect of CIIA on apoptotic cell death induced by TNF-  or
H2O2 (Fig. 7 C). 293-CIIA cells were more resistant to both
Figure 6.  CIIA inhibits the nuclease 
activity of CAD. (A) In vitro nuclease 
activity of CAD was examined by incu-
bating 1  g His-CAD–ICAD-L complex 
and 5  g Jurkat chromosomal DNA with 
2  g GST, 2  g GST-ICAD-L, or 2  g 
in left panel or the indicated amounts 
in right panel of GST-CIIA in the absence 
or presence of caspase-3. (B) In vitro 
nuclease activity of CAD was examined 
in the presence of 2  g GST-fused CIIA 
variants as in A. (C) 1  g CAD–T7-ICAD 
complex was treated with 200 ng re-
combinant caspase-3 in the absence 
or presence of 4  g GST-CIIA for 2 h 
at 37 C. The reaction mixture was ana-
lyzed by SDS-PAGE and immunoblot-
ting with mouse anti-T7 mAb. (D) 1  g 
His-CAD–ICAD-L complex was pre-
treated with 200 ng caspase-3 for 2 h 
at 37 C, where indicated, and examined 
for the nuclease activity of CAD in the 
absence or presence of 2  g GST-CIIA. 
(E) Overexpressed CIIA inhibits the 
nuclease activity of CAD in 293T cells. 
293T cells were transfected for 48 h with 
indicated combinations of expression 
vectors encoding CAD-Flag, ICAD-L, 
constitutively active caspase-3, and 
HA-CIIA. Chromosomal DNA from the 
transfected cells was examined for 
DNA fragmentation (Liu et al., 1998).T
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TNF- – and H2O2-induced apoptosis, compared with 293-
neo cells. CIIA also protected 293-CIIA cells against apopto-
sis induced by Daxx, an activator of ASK1 (Chang et al.,
1998; unpublished data).
To further investigate the inhibitory effect of CIIA on
apoptosis, we transiently transfected 293T cells with expres-
sion vectors for full-length CIIA, CIIA- N, and CIIA- C,
and measured TNF- – and H2O2-induced apoptosis as well
Figure 7.  CIIA inhibits apoptosis. (A) CIIA inhibits TNF- –stimulated ASK1 activity in 293-CIIA cells. 293T cells were stably transfected 
with pcDNA3 empty vector or pcDNA3-HA-CIIA, yielding 293-neo control or 293-CIIA cells, respectively. Heterogeneous populations of the 
stably transfected cells were used to avoid clonal variations. The cells were untreated or treated with 20 ng/ml TNF-  for 20 min. Cell lysates 
were subjected to immunoprecipitation with anti-ASK1 or anti-JNK1 antibodies, and the resulting immunoprecipitates were assayed for the 
kinase activities of endogenous ASK1 or JNK1 by immunocomplex kinase assay. Cell lysates were also examined by immunoblot analysis 
with anti-ASK1, anti-JNK1, or anti-HA antibody. (B) CIIA decreases TNF- –induced DNA fragmentation in 293-CIIA cells. 293-neo and 293-CIIA 
cells were treated with 20 ng/ml TNF-  plus 1  g/ml actinomycin D for the indicated time periods. Chromosomal DNA was obtained from 
the cells and examined for DNA fragmentation. (C) CIIA suppresses TNF- – and H2O2-induced apoptosis. 293-neo and 293-CIIA cells were 
exposed to 20 ng/ml TNF-  plus 1  g/ml actinomycin D (TNF- /ActD) or 500  M H2O2, incubated overnight, and assayed for apoptotic cell 
death by flow cytometry with annexin V staining. Data are mean   SEM from three experiments. (D and E) 293T cells were transfected with 
plasmids encoding (D) HA-ASK1 or (E) HA-JNK1 alone or together with full-length CIIA, CIIA- N, or CIIA- C. After 48 h of transfection, the 
cells were untreated or treated with 500  M H2O2 or 20 ng/ml TNF-  for 20 min. Cell lysates were assayed for (D) ASK1 or (E) JNK1 activity 
by immunocomplex kinase assay with the use of anti-HA antibody. Cell lysates were also examined by immunoblot analysis with anti-HA 
and anti-Flag antibodies. (F) 293T cells were transiently transfected for 50 h with plasmids encoding full-length CIIA, CIIA- N, or CIIA- C. 
The cells were untreated or treated with 20 ng/ml TNF-  plus 1  g/ml actinomycin D (TNF- /ActD) or 500  M H2O2, further incubated overnight, 
and assayed for apoptosis by DAPI staining. The data are presented as the mean   SEM. The statistical significance is designated by an asterisk. 
P   0.01 versus control (mock transfection).T
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as ASK1 and JNK1 activation in the transfected cells. CIIA-
 N is a CIIA mutant that interacted with ASK1 (Fig. 3 A),
but not with CAD (Fig. 4 A). CIIA- C is a CIIA mutant
that bound and inhibited CAD (Figs. 4 A and 6 B), but it
did not interact with ASK1 (Fig. 3 A). CIIA and CIIA- N
inhibited the TNF- – and H2O2-stimulated activities of
ASK1 (Fig. 7 D) and JNK1 (Fig. 7 E), whereas CIIA- C
had little effect, if any, on the TNF- – and H2O2-stimu-
lated activities of ASK1 (Fig. 7 D) and JNK1 (Fig. 7 E).
CIIA and CIIA- N inhibited TNF- – and H2O2-induced
apoptosis in the transfected cells (Fig. 7 F). In contrast, the
effect of CIIA- C was marginal. Together, these results sug-
gest that the inhibition of ASK1 activity by CIIA is crucial
for the antiapoptotic function of CIIA.
CIIA antisense oligonucleotides prevent CIIA from 
inhibiting ASK1 activation and DNA fragmentation
To test the role of endogenous CIIA protein in stress-
induced ASK1 activation and DNA fragmentation, CIIA
antisense oligonucleotides were transfected into L929 cells
(Fig. 8 A). Among the antisense oligonucleotides used,
CIIA-AS3 most effectively blocked the expression of
endogenous CIIA in L929 cells. Inhibition of CIIA ex-
pression by CIIA-AS3 resulted in an increase in the UV-
stimulated activity of endogenous ASK1 in L929 cells.
Transfection of L929 cells with antisense oligonucleotides
CIIA-AS3 also resulted in an increase in the H2O2- and
TNF- –stimulated activity of endogenous ASK1 (Fig. 8
B). Moreover, treatment of cells with CIIA-AS3 markedly
enhanced DNA fragmentation and apoptosis even in the
absence of any apoptotic stimuli (Fig. 8, C and D). Either
UV- or TNF- –induced DNA fragmentation also in-
creased in L929 cells transfected with CIIA-AS3, compared
with the mock-transfected cells or cells transfected with the
corresponding sense oligonucleotides (Fig. 8 C). Further-
more, transfection of the cells with CIIA-AS3 enhanced
UV-, TNF- –, and H2O2-induced apoptosis, compared
with the mock-transfected cells or cells transfected with the
Figure 8.  CIIA antisense oligonucleotides block the inhibitory effect of CIIA on ASK1 activation and DNA fragmentation. (A) CIIA antisense 
oligonucleotides block the expression of endogenous CIIA and enhance UV-induced ASK1 activation in L929 cells. L929 cells were transfected 
for 48 h with CIIA antisense oligonucleotides (CIIA-AS1 to 4). The cells were treated with 80 J/m
2 UV light and incubated further for 20 min. 
The cell lysates were immunoblotted to monitor the intracellular levels of CIIA and ASK1, and also examined for ASK1 activity by immuno-
complex kinase assay using anti-ASK1 antibody. (B) CIIA-AS3 enhances ASK1 activity stimulated by H2O2 and TNF-  in L929 cells. L929 
cells were transfected with CIIA-AS3 ( ) or its complementary sense oligonucleotides ( ). After 48 h of transfection, the cells were untreated 
or treated with 500  M H2O2 or 20 ng/ml TNF-  for 20 min. The cell lysates were assayed for ASK1 activity as in A. (C and D) CIIA antisense 
oligonucleotides enhance DNA fragmentation and apoptosis. L929 cells were mock-transfected or transfected with CIIA-AS3 (AS3) or its 
complementary sense oligonucleotides (Sense3). After 48 h of transfection, the cells were untreated ( ) or treated ( ) with 80 J/m
2 UV light, 
20 ng/ml TNF-  plus 10  g/ml cycloheximide (TNF/CHX), or 500  M H2O2 and incubated overnight. The cells were then examined for (C) 
DNA fragmentation or for (D) apoptosis by DAPI staining. Data are the mean of triplicate determinations   SEM. The data represent results 
from three independent experiments.T
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sense oligonucleotides (Fig. 8 D). Collectively, these data
suggest that CIIA functions as a natural antagonist against
ASK1-mediated signaling and DNA fragmentation.
Discussion
Here, we identified a new protein, CIIA, which functions as
an antagonist of both ASK1 and CAD activities. ASK1 has
been shown to function in apoptosis triggered by a variety of
cellular stresses and proinflammatory cytokines (Ichijo et al.,
1997; Chang et al., 1998; Chen et al., 1999). Oligomeriza-
tion of ASK1 is shown to be associated with the mechanism
for ASK1 activation (Gotoh and Cooper, 1998; Nishitoh et
al., 1998; Hoeflich et al., 1999; Liu et al., 2000). Our results
suggest that CIIA, by binding ASK1, interferes with ASK1
oligomerization and blocks ASK1 activation. Interestingly,
other ASK1 inhibitors, including thioredoxin and GST ,
also block ASK1 oligomerization (Saitoh et al., 1998; Cho et
al., 2001), suggesting that the mitigation of ASK1 oligomer-
ization may be a general mechanism underlying the negative
regulation of ASK1. It is also noteworthy that ASK1 does
not phosphorylate CIIA (unpublished data).
The NH2-terminal region of CAD contains a CIDE-N
domain, which is conserved in ICAD/DFF45 and CIDE-B
(Inohara et al., 1998; Sakahira et al., 1998). This domain of
CAD is essential for interaction with ICAD-L, and thus, for
regulation of the nuclease activity of CAD (McCarty et al.,
1999a,b; Sakahira et al., 1999). Our data show that CIIA as-
sociates with the CIDE-N domain of CAD. Interestingly,
CIIA does not associate with ICAD-L even though ICAD-L
also contains a CIDE-N domain. Furthermore, CIIA can as-
sociate with CAD regardless of the presence of ICAD-L.
The physical association of CIIA with CAD leads to the in-
hibition of the nuclease activity of CAD.
Upon exposure of cells to a variety of apoptotic stimuli,
CIIA appears to suppress ASK1 activation and CAD-medi-
ated DNA fragmentation. In this regard, it was reported
recently that ASK1 activation enhances cytochrome c re-
lease from the mitochondria into the cytoplasm, as well as
the subsequent activation of caspase-9 and downstream
caspases (Hatai et al., 2000). The activated caspase cascade
may stimulate downstream apoptotic pathways including
CAD-mediated DNA fragmentation. Thus, CIIA may an-
tagonize the ASK1-mediated apoptotic pathway with high
efficiency by inhibiting ASK1 activation at an early stage of
apoptosis and induction of ASK1-induced DNA fragmen-
tation at a later stage.
On the basis of our findings, we propose that CIIA func-
tions as a natural inhibitor of both ASK1 and CAD. The
dual function of CIIA may constitute an integral part of the
mechanism by which the apoptotic pathways in the cyto-
plasm and in the nucleus are controlled. In addition, while
the present paper was in preparation, a human counterpart
of mouse CIIA was reported. This human protein, named
hVPS28, interacts with the Tsg101 protein and appears to
be involved in endosomal sorting (Bishop and Woodman,
2001). Tsg101, originally discovered as a tumor susceptibil-
ity gene, has been implicated in transcriptional regulation
and neoplastic transformation (Li and Cohen, 1996). There-
fore, it is tempting to propose that CIIA may be a multifac-
eted regulator that associates with intracellular signaling net-
works for apoptosis, cellular stress, and tumorigenesis.
Materials and methods
Antibodies
Rabbit anti-ASK1 and anti-hexahistidine (His) pAbs were purchased from
Santa Cruz Biotechnology. Rabbit anti-CAD and anti-ICAD pAbs were pur-
chased from Oncogene Research Products. Affinity-purified rabbit anti-
CIIA pAb was produced from rabbits immunized with His-CIIA protein.
Mouse anti-HA, anti-Flag, anti-Myc, and anti-H7 mAbs were purchased
from Roche Molecular Biochemicals, Stratagene, Cell Signaling Biotech-
nology, and Novagen, respectively.
DNA constructs
ASK1 deletion mutants, ASK- N, ASK1- C, and ASK1-NT, were generated
by PCR, and subcloned into pcDNA3 vector (Invitrogen; Cho et al., 2001).
Daxx(498–740) was a gift from S.H. Kim (Sungkyunkwan University, Su-
won, Korea). JNK1, TRAF2, and caspase-3 cDNA clones were from R.J.
Davis (University of Massachusetts, Worchester, MA), D.V. Goeddel Tu-
larik Inc., South San Francisco, CA), and Dr. Y.K. Chung (Kwangju Institute
of Science and Technology, Kwangju, Korea), respectively. CAD and
ICAD-L cDNAs were obtained by RT-PCR (Park et al., 2000). The cDNA of
the mouse CIIA gene was obtained from the screening of a mouse adult
brain cDNA library (CLONTECH Laboratories, Inc.) and 5 -RACE. Human
CIIA cDNA was obtained from human fetal brain total RNA (CLONTECH
Laboratories, Inc.) by RT-PCR using primers CIIA-H1 (5 -CCCAGAGCCTA-
GAGGATGTTTCATGG-3 ) and CIIA-H2 (5 -CCGGGCTCAGGCATGCAG-
GAAGCG-3 ), whose nucleotide sequences were determined from the hu-
man cDNA EST clones (zw 80e08.s1; zw 80e08.r1).
Yeast two-hybrid screening
Yeast two-hybrid screening was performed according to the manufac-
turer’s protocol (CLONTECH Laboratories, Inc.). In brief, a full-length
cDNA of either ASK1 or CAD was inserted adjacent to the LexA DNA-
binding domain in the pLexA bait vector. About 2   10
6 clones of a mouse
adult brain cDNA library (CLONTECH Laboratories, Inc.) were screened
using Saccharomyces cerevisiae EGY48[p8op-lacZ]. Positive clones were
rescued from yeast cotransformants using Escherichia coli KC8 cells, and
the cDNA inserts in the rescued plasmids were sequenced.
Isolation of the mouse CIIA cDNA
A 714-bp fragment of CIIA cDNA that had been isolated from the yeast
two-hybrid screening using ASK1 as the bait was used as a probe to isolate
cDNA clones from a mouse brain Lambda ZAPII cDNA library (Strat-
agene). Plaque hybridization was performed at 42 C for 12 h in 5  SSPE,
0.1% SDS, 5  Denhardt’s solution, 50% formamide, and 100  g/ml dena-
tured salmon sperm DNA. Positive cDNA inserts were in vivo excised, re-
covered in a pBluescript SK( ) plasmid, and sequenced. To obtain the 5 
region of mouse CIIA, 5 -RACE was performed using mouse brain total
RNA (CLONTECH Laboratories, Inc.) and a 5 -RACE kit (Roche Molecular
Biochemicals). The gene-specific antisense primer sequences used for 5 -
RACE were 5 -GGGAGCGGGAGAAGTATGACAACATGG-3  and 5 -
GGATGTTCCACGGGATCCCGGCTAC-3 .
Northern blot analysis
A 714-bp fragment of mouse CIIA cDNA excised by BamHI and AccI was
labeled with  -[
32P]ATP by a random priming method and hybridized with
a mouse multiple-tissue mRNA blot (CLONTECH Laboratories, Inc.).
Cell culture, transfection, and apoptotic cell death
293T, L929, and HeLa cells were cultured in DME supplemented with
10% FBS. DNA transfections were performed with the LipofecAMINE
TM
(GIBCO BRL), GenePorter 2 (Gene Therapy Systems, Inc.), calcium phos-
phate, or electroporation method. Apoptotic cell death was measured by
flow cytometry (Facs
®Calibur; Becton Dickinson) with annexin V staining
or by DAPI staining. For annexin V staining, cultured cells were resus-
pended in binding buffer (10 mM Hepes/NaOH, pH 7.4, 140 mM NaCl,
and 2.5 mM CaCl2) and stained with FITC–annexin V and propidium io-
dide. Apoptotic cells (Annexin V–FITC positive, propidium iodide nega-
tive) were analyzed by flow cytometry (Facs
®Calibur; Becton Dickinson).
For DAPI staining, cultured cells were transfected with pEGFP (CLON-
TECH Laboratories, Inc.) and expression vectors for the indicated proteins.
After transfection, the cells were washed twice with PBS solution. Next,T
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the cells were fixed with 0.25% glutaraldehyde, permeabilized with 0.1%
Triton X-100, and stained with DAPI. The DAPI-stained nuclei in GFP-pos-
itive cells were examined for apoptotic morphology by fluorescence mi-
croscopy. The percentage of GFP-expressing cells that were apoptotic was
determined from three independent dishes.
Coimmunoprecipitation analysis
Cells were lysed in buffer A that contained 20 mM Tris-HCl, pH 7.4, 150
mM sodium chloride, 1% Triton X-100, 1% deoxycholate, 12 mM
 -glycerphosphate, 10 mM sodium fluoride, 5 mM EGTA, and 1 mM
PMSF. The cell lysates were subjected to immunoprecipitation using the
appropriate antibodies. The resulting immunoprecipitates were analyzed
by SDS-PAGE and immunoblotting with the use of an ECL detection
method (Amersham Biosciences).
Immunocomplex kinase assays
Cell lysates were subjected to immunoprecipitation using the proper anti-
body, and the resulting immunopellets were assayed for the indicated pro-
tein kinases as described previously (Park et al., 2001). Phosphorylated
substrates were resolved by SDS-PAGE, and phosphorylation was quanti-
fied using a phosphoimager (model BAS2500; Fuji). GST-MKK6(K82A) and
GST-c-Jun(1–79) were used as substrates for ASK1 and JNK/SAPK.
In vitro binding assay
CIIA, ASK1, CAD, or their variants were in vitro translated in the pres-
ence of [
35S]methionine using the TNT reticulocyte lysate system (Pro-
mega). The 
35S-labeled proteins were incubated at 4 C for 3 h with
GST-fused proteins immobilized on glutathione-Sepharose beads or with
T7-tagged proteins immobilized on anti-T7 antibody/protein G–Sepha-
rose beads in a buffer containing 50 mM Tris, pH 7.5, 150 mM NaCl, 2
mM EDTA, 1 mM DTT, 0.1% NP-40, and 5 mg/ml BSA. The bound 
35S-
labeled proteins were eluted from the beads and analyzed by SDS-PAGE
and autoradiography.
Luciferase reporter assay of c-Jun–dependent transcription
The transcription-stimulating activity of c-Jun was measured with the Path-
Detect luciferase reporter kit (Stratagene). 293T cells were transfected for
48 h with luciferase reporter plasmid pFR-Luc, pFA2-c-Jun, and pcDNA3-
 -gal and the indicated combinations of plasmids for ASK1 and CIIA. The
soluble fraction of the cell lysates was assayed for luciferase activity using
a luciferase assay kit (Promega) and for  -galactosidase activity. The lu-
ciferase activities in the transfected cells were normalized with reference
to the  -galactosidase activities in the same cells.
CAD and DNA fragmentation assays
A His-tagged CAD–ICAD-L complex was bacterially expressed using
pET23b (Novagen) and purified with Ni
2 -NTA–agarose (QIAGEN). 1  g
of the His-CAD–ICAD-L complex protein was incubated for 2 h at 37 C
with 2  g GST-CIIA or its various deletion mutants in the absence or pres-
ence of 200 ng of recombinant caspase-3 in 50  l of a nuclease reaction
buffer containing 10 mM Hepes, pH 7.5, 1 mM EGTA, 5 mM MgCl2, 50
mM NaCl, 1 mg/ml BSA, and 0.1 mg/ml chromosomal DNA extracted
from Jurkat cells (Halenbeck et al., 1998). CAD-mediated DNA fragmenta-
tion was analyzed by electrophoresis on a 2% agarose gel and staining
with ethidium bromide. DNA fragmentation in 293T cells was measured
as described previously (Liu et al., 1998) after 48 h of transfection with ex-
pression vectors encoding CIIA, CAD, ICAD-L, and prodomain-deleted ac-
tive caspase-3 (Srinivasula et al., 1998).
Glycerol gradient centrifugation
NIH 3T3 cells stably expressing HA-CIIA were homogenized using a
Dounce homogenizer in PBS solution containing 1 mM PMSF, 2  g/ml
leupeptin, and 2  g/ml aprotinin. Cell extracts were subjected to centrifu-
gation at 1,000 g for 10 min, and the resulting soluble fraction was layered
on the top of linear 15–35% (wt/wt) glycerol gradient adjusted to 20 mM
Tris-HCl, pH 6.7, 150 mM MgCl2, and 10 mM KCl. Centrifugation was
performed at 39,000 rpm for 18 h at 4 C using a rotor (model SW40Ti;
Beckman Coulter). 22 fractions of the soluble fraction were collected se-
quentially from the bottom and equal volumes were analyzed by SDS-
PAGE and immunoblotting with the use of anti-HA, anti-ASK1, anti-CAD,
and anti-ICAD antibodies.
Online supplemental material
Fig. S1 shows subcellular distribution of ectopic CIIA, ASK1, and CAD in
NIH 3T3 cells. Fig. S2 shows the effect of CIIA on the binding of ASK1 with
TRAF2, GSTM1, or Daxx. Fig. S3 shows coimmunoprecipitation data indi-
cating that CIIA does not bind JNK1, MEKK1, or c-Jun. Fig. S4 shows an ef-
fect of CIIA on MEKK1 activity. Online supplemental material is available
at http://www.jcb.org/cgi/content/full/jcb.200303003/DC1.
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